NL8401120A - Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek. - Google Patents

Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek. Download PDF

Info

Publication number
NL8401120A
NL8401120A NL8401120A NL8401120A NL8401120A NL 8401120 A NL8401120 A NL 8401120A NL 8401120 A NL8401120 A NL 8401120A NL 8401120 A NL8401120 A NL 8401120A NL 8401120 A NL8401120 A NL 8401120A
Authority
NL
Netherlands
Prior art keywords
virus
disease
marek
mdv
vaccine
Prior art date
Application number
NL8401120A
Other languages
English (en)
Dutch (nl)
Original Assignee
Centraal Diergeneeskundig Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Centraal Diergeneeskundig Inst filed Critical Centraal Diergeneeskundig Inst
Priority to NL8401120A priority Critical patent/NL8401120A/nl
Priority to AT85200461T priority patent/ATE56364T1/de
Priority to DE8585200461T priority patent/DE3579617D1/de
Priority to EP85200461A priority patent/EP0159743B1/en
Priority to PCT/NL1985/000014 priority patent/WO1985004588A1/en
Priority to AU41561/85A priority patent/AU574164B2/en
Priority to HU851448A priority patent/HU194496B/hu
Priority to IN234/CAL/85A priority patent/IN163229B/en
Priority to IL74809A priority patent/IL74809A/xx
Priority to ES541930A priority patent/ES8605680A1/es
Priority to ZA852564A priority patent/ZA852564B/xx
Priority to US06/720,176 priority patent/US4673572A/en
Priority to DD85274954A priority patent/DD232822A5/de
Priority to MX851025U priority patent/MX7718E/es
Priority to CA000478672A priority patent/CA1251397A/en
Priority to JP60075246A priority patent/JPS6123A/ja
Priority to YU599/85A priority patent/YU44687B/xx
Publication of NL8401120A publication Critical patent/NL8401120A/nl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/255—Marek's disease virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/816—Viral vaccine for avian species, e.g. poultry or other birds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
NL8401120A 1984-04-09 1984-04-09 Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek. NL8401120A (nl)

Priority Applications (17)

Application Number Priority Date Filing Date Title
NL8401120A NL8401120A (nl) 1984-04-09 1984-04-09 Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.
AT85200461T ATE56364T1 (de) 1984-04-09 1985-03-25 Lebender gereinigter impfstoff gegen die marek'sche krankheit.
DE8585200461T DE3579617D1 (de) 1984-04-09 1985-03-25 Lebender gereinigter impfstoff gegen die marek'sche krankheit.
EP85200461A EP0159743B1 (en) 1984-04-09 1985-03-25 Live purified marek's disease vaccine
PCT/NL1985/000014 WO1985004588A1 (en) 1984-04-09 1985-03-27 Live purified marek's disease vaccine and process for the preparation thereof
AU41561/85A AU574164B2 (en) 1984-04-09 1985-03-27 Marek,s disease vaccine
HU851448A HU194496B (en) 1984-04-09 1985-03-27 Process for preparing a living vaccine against marek disease
IN234/CAL/85A IN163229B (cs) 1984-04-09 1985-03-28
IL74809A IL74809A (en) 1984-04-09 1985-04-03 Live purified marek's disease vaccine
ES541930A ES8605680A1 (es) 1984-04-09 1985-04-03 Procedimiento de obtener un preparado virico contra la enfermedad de marek.
ZA852564A ZA852564B (en) 1984-04-09 1985-04-04 Live purified marek's disease vaccine
US06/720,176 US4673572A (en) 1984-04-09 1985-04-05 Live purified Marek's disease vaccine
DD85274954A DD232822A5 (de) 1984-04-09 1985-04-08 Verfahren zur herstellung eines viruspraeparates gegen die mareksche gefluegelkrankheit
MX851025U MX7718E (es) 1984-04-09 1985-04-08 Procedimiento para preparar una vacuna anti marek avicola
CA000478672A CA1251397A (en) 1984-04-09 1985-04-09 Live purified marek's disease vaccine
JP60075246A JPS6123A (ja) 1984-04-09 1985-04-09 ウイルス調製物
YU599/85A YU44687B (en) 1984-04-09 1985-04-09 Process for making alive purified vaccine for marek's disseases

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
NL8401120 1984-04-09
NL8401120A NL8401120A (nl) 1984-04-09 1984-04-09 Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.

Publications (1)

Publication Number Publication Date
NL8401120A true NL8401120A (nl) 1985-11-01

Family

ID=19843774

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8401120A NL8401120A (nl) 1984-04-09 1984-04-09 Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.

Country Status (17)

Country Link
US (1) US4673572A (cs)
EP (1) EP0159743B1 (cs)
JP (1) JPS6123A (cs)
AT (1) ATE56364T1 (cs)
AU (1) AU574164B2 (cs)
CA (1) CA1251397A (cs)
DD (1) DD232822A5 (cs)
DE (1) DE3579617D1 (cs)
ES (1) ES8605680A1 (cs)
HU (1) HU194496B (cs)
IL (1) IL74809A (cs)
IN (1) IN163229B (cs)
MX (1) MX7718E (cs)
NL (1) NL8401120A (cs)
WO (1) WO1985004588A1 (cs)
YU (1) YU44687B (cs)
ZA (1) ZA852564B (cs)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4456101A (en) * 1980-11-08 1984-06-26 Honda Giken Kogyo Kabushiki Kaisha Vehicular brake operating system
JP2508625B2 (ja) * 1985-08-30 1996-06-19 ソニー株式会社 半導体レ−ザ−
FR2598596B1 (fr) * 1986-05-15 1990-10-19 Sanofi Elf Bio Ind Procede de traitement du lait en vue de l'obtention de fromages
US5849299A (en) * 1991-06-28 1998-12-15 The United States Of America As Represented By The Secretary Of Agriculture Attenuated revertant serotype 1 marek's disease vaccine
WO1993023078A1 (en) * 1992-05-19 1993-11-25 Viktoria Alexeevna Lukina Vaccine for prophylaxis of marek disease of birds and method of its preparation
IL114501A (en) * 1994-07-14 1999-08-17 Akzo Nobel Nv Marek's disease virus vaccine
EP0703294A1 (en) * 1994-07-14 1996-03-27 Akzo Nobel N.V. Marek's disease virus vaccine
EP0748867A1 (en) * 1995-06-12 1996-12-18 Duphar International Research B.V Marek's disease vaccine
US5989805A (en) * 1995-10-27 1999-11-23 Board Of Trustees Operating Michigan State University Immortal avian cell line to grow avian and animal viruses to produce vaccines
US5993822A (en) * 1996-06-04 1999-11-30 University Of Georgia Research Foundation, Inc. Modified live avian polymavirus vaccine in psittacine birds
EP1038952A3 (en) * 1998-12-09 2001-06-27 Pfizer Products Inc. Processes for preparation of Marek's Disease Virus using continuous avian cell lines
RU2144377C1 (ru) * 1999-06-28 2000-01-20 Всероссийский научно-исследовательский институт защиты животных Бивалентная вакцина против болезни марека и способ ее изготовления
US20130251737A1 (en) 2012-03-22 2013-09-26 Merial Limited Modified Mareks Disease Virus, and Vaccines Made Therefrom

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1292803A (en) * 1968-11-18 1972-10-11 Nat Res Dev Improvements relating to the production of antigens
US3642574A (en) * 1970-04-29 1972-02-15 Us Agriculture Method for producing vaccine for immunization of poultry against marek{3 s disease
US3783098A (en) * 1971-08-10 1974-01-01 Cornell Res Foundation Inc Highly potent,viable and stable cellfree virus preparations from cells infected with cell-associated viruses and method for obtaining the same
US4160024A (en) * 1978-05-01 1979-07-03 Cornell Research Foundation, Inc. Marek's disease vaccine

Also Published As

Publication number Publication date
DD232822A5 (de) 1986-02-12
HUT38542A (en) 1986-06-30
CA1251397A (en) 1989-03-21
ZA852564B (en) 1985-11-27
JPH0317808B2 (cs) 1991-03-11
ES8605680A1 (es) 1986-04-16
IN163229B (cs) 1988-08-27
US4673572A (en) 1987-06-16
IL74809A (en) 1990-09-17
AU4156185A (en) 1985-11-01
JPS6123A (ja) 1986-01-06
WO1985004588A1 (en) 1985-10-24
YU44687B (en) 1990-12-31
YU59985A (en) 1988-06-30
AU574164B2 (en) 1988-06-30
MX7718E (es) 1990-10-10
EP0159743B1 (en) 1990-09-12
EP0159743A1 (en) 1985-10-30
DE3579617D1 (de) 1990-10-18
IL74809A0 (en) 1985-07-31
HU194496B (en) 1988-02-29
ATE56364T1 (de) 1990-09-15
ES541930A0 (es) 1986-04-16

Similar Documents

Publication Publication Date Title
KR0156732B1 (ko) 연속 셀 라인에서의 ibdv 생성
Smith et al. The oncogenic effects of nontransforming viruses from avian myeloblastosis virus
NL8401120A (nl) Viruspreparaat, waarmee gevaccineerd kan worden tegen de ziekte van marek.
CN109207436B (zh) 一株i群4型禽腺病毒毒株及其应用
Bülow Immunological effects of reticuloendotheliosis virus as potential contaminant of Marek's disease vaccines
EP0687471A1 (en) Production of an efficacious toxoplasma gondii bradyzoite vaccine in tissue culture
US3642574A (en) Method for producing vaccine for immunization of poultry against marek{3 s disease
Shimizu et al. The dual origin of noninfective Rous sarcomas
SE444453B (sv) Sett att isolera en ny stam av rabiesvirus
AA et al. Study on propagation and adaptation of EDS-76 avian adenovirus in duck and SPF primary embryonic chicken cell culture comparison to duck and SPF embryonated Chicken Eggs
Geerligs et al. Efficacy and safety of cell associated vaccines against Marek's disease virus grown in a continuous cell line from chickens
US5789231A (en) Marek's disease vaccine
KR20000069501A (ko) 뉴우캐슬병에 대한 난내 백신화
Cho A possible association between plaque type and pathogenicity of Marek's disease herpesvirus
Mack et al. Serological response in chickens to beta-propiolactone treated Newcastle disease virus
McNeilly et al. Bursal lymphocyte proliferation in the presence of phorbol myristate acetate: effect of IBDV strains on the proliferation response
Mancini et al. Cultivation of avian encephalomyelitis virus in vitro. 1. In chick embryo neuroglial cell culture
KR20000070736A (ko) 전염성 활액낭염 백신
Cho Studies of turkey herpesvirus viremia in two strains of vaccinated chickens: strain difference and effects of vaccine dose
v Bülow et al. Plaque Assay of Turkey Herpesvirus and Attenuated Marek's* Disease Virus
Cho An improved method for extracting cell-free herpesviruses of Marek's disease and turkeys from infected cell cultures
Darbyshire Organ culture in avian virology: a review
Geerligs et al. Efficacy and Safety of Cell-Associated Vaccines Against Marek's Disease Virus Grown in QT35 Cells or JBJ-1 Cells
JPS6244528B2 (cs)
Bubel et al. An improved method for detection of ganglionic latency in herpes simplex virus type-1 infected guinea pigs

Legal Events

Date Code Title Description
A1B A search report has been drawn up
BV The patent application has lapsed